Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Business business expansion

SciBase receives additional Castle Biosciences order

Analysis based on 6 articles · First reported Sep 08, 2026 · Last updated Sep 08, 2026

Sentiment
20
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The order strengthens SciBase's revenue pipeline and validates its collaboration with Castle Biosciences, potentially boosting investor confidence in SciBase's growth prospects. For Castle Biosciences, the order advances its clinical development efforts in dermatology, supporting its strategic initiatives.

Medical Devices Biotechnology

SciBase Holding AB announced on September 8, 2026 that it received an additional order from Castle Biosciences under their ongoing collaboration. The order, valued at approximately $0.6 million (MSEK 5), includes the portable Nevisense Go pen device and electrodes. It will accelerate the current clinical study on predicting relapses in atopic dermatitis and support preparations for a second clinical study. Deliveries are expected to start in Q4 2026. This order follows the collaboration and license agreement signed in 2025 and signals the expansion of the partnership.

stock
SciBase is the recipient of the order, which provides additional revenue and validates its technology and collaboration. This order supports its growth and strengthens its position in dermatology diagnostics.
Importance 100.0 Sentiment 60.0
stock
Castle Biosciences placed the order to accelerate its clinical studies, advancing its pipeline in atopic dermatitis. This reflects its commitment to expanding its molecular diagnostics portfolio.
Importance 80.0 Sentiment 40.0
per
Pia Renaudin, CEO of SciBase, commented on the order, highlighting the fast pace of the collaboration. Her role is primarily communicative, with no direct financial impact.
Importance 20.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.